Clinical Trials
7 trialsNCT00673010 2025-10-09
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02393690 2024-07-26
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Academic and Community Cancer Research United
Phase 2 Completed
NCT04072731 2019-08-28
SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer
People's Hospital of Zhengzhou University
Completed
NCT02375451 2017-06-26
Effect of Childhood Radioiodine Therapy on Salivary Function
Boston Children's Hospital
Completed
NCT01413113 2015-11-05
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
University of Washington
Phase 1 Completed
NCT01150318 2013-08-07
SAPIRA
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT00439478 2007-11-14
Dental Safety Profile of High-Dose Radioiodine Therapy
University Hospital, Basel, Switzerland
Completed